Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

MANCHESTER, England, February 6 /PRNewswire/ --

The Bishop of Manchester has made a series of serious allegations against Dr. Gunther von Hagens, former University of Heidelberg researcher, inventor of the science of Plastination, and creator of BODY WORLDS. In a press release dated the 04 February and at a Press Conference at Manchester Cathedral on the 05 February, the Bishop has castigated the forthcoming BODY WORLDS 4 exhibition, to be hosted by the Museum of Science and Industry, Manchester, from the 22 February to 29 June, 2008.

SANTA BARBARA, California, February 6 /PRNewswire/ --

- 724's Seamless All-Ways Messaging and Seamless Follow-Me Messaging unlock the potential for revenue growth with next generation messaging applications.

724 Solutions, a leading provider of next generation mobile data solutions enabling seamless communications in an IP-based world, announced the launch of two market driven Seamless Messaging applications: Seamless All-Ways Messaging and Seamless Follow-Me Messaging, which enable mobile operators and service providers to connect previously isolated messaging domains, grow messaging connectivity across networks, stimulate messaging usage and increase messaging revenues.

NEW YORK, February 5 /PRNewswire/ --

- Forum for Accomplished Women Entrepreneurs Launches in London

The Women Presidents' Organization (WPO) will launch a new chapter in London, England on Wednesday, February 13 introducing the first WPO presence in the United Kingdom. The WPO is the premier organization for accomplished woman entrepreneurs grossing at least US$2 million in annual revenue (US$1 million for a service-based business), or the pound equivalent.

INDIANAPOLIS, February 5 /PRNewswire/ --

- Global contest seeks expressions of the triumphs and challenges of living with diabetes through art, essay, poetry, photography and music

Eli Lilly and Company, the International Diabetes Federation (IDF), and the International Society for Pediatric and Adolescent Diabetes (ISPAD) today announced that the entry deadline for submissions into the global competition will be extended until 31 March 2008. The global Inspired by Diabetes Creative Expression Competition is a contest asking people with diabetes, as well as their family and friends, to express how diabetes has impacted their lives -- and share those stories with others around the world. The original deadline for entries was 31 January 2008.

HEIDELBERG, Germany, February 5 /PRNewswire/ --

During a lengthy interview with a reporter from a tabloid in Guben, Germany on Feb 4. 2008 anatomist, Dr. Gunther von Hagens explained his views on anatomy, the poor access to medical knowledge by lay people, and his own professional evolution from male nurse, to anesthesiologist, to Ivory Tower academic, to public scientist.

Dr. von Hagens believes that to differentiate between experts and laypersons points to an inherent bias that could lead to the colonizing of knowledge by the medical and scientific elite. Thus, he floated the idea that plastinates ought to be distributed to qualified individuals including laypersons. In a moment of scientific bravado on behalf of lay people, Dr. von Hagens claimed the enterprise as feasible and active, and went so far as to venture how such a plan would operate.

BOSTON, February 5 /PRNewswire/ --

A new study led by researchers at Joslin Diabetes Center has identified insulin resistance in the liver as a key factor in the cause of metabolic syndrome and its associated atherosclerosis, disorders that put tens of millions of Americans at high risk of cardiovascular disease.

The findings, published in the February issue of Cell Metabolism, provide not only an understanding of how metabolic syndrome occurs, but also pinpoint a target for treatment of the condition. This represents the work of Sudha Biddinger, M.D., Ph.D., and a team led by C. Ronald Kahn, M.D., Head of the Joslin Research Section on Obesity and Hormone Action and the Mary K. Iacocca Professor of Medicine at Harvard Medical School.